Slideshow

Recognizing Axial Spondyloarthritis in Primary Care

Author(s):

Back pain is the second leading symptom prompting a visit to a primary care physician. Here, we highlight a review of axial spondyloarthritis from Mayo Clinic Proceedings. The review aims to help primary care physicians detect this condition and know when to refer to a rheumatologist.

Back pain is the second leading symptom prompting a visit to a primary care physician, with around 20 percent of people aged 20 to 59 years reporting chronic low back pain. Axial spondyloarthritis, which affects around 1 percent of the U.S. population, is an important cause of back pain, with a characteristic pattern referred to as inflammatory back pain. Despite new and effective therapies available for the treatment of active axSpA, making early diagnosis of critical importance, a delay of several years between symptom onset and diagnosis is common in axSpA.

In this slideshow, we highlight a review of axSpA from Mayo Clinic Proceedings. The review aims to help primary care physicians detect this under recognized condition and know when to refer to a rheumatologist.

__________________

REFERENCE

Marina N Magrey, Abhijeet S Danve,Joerg Ermann, et al. “Recognizing Axial Spondyloarthritis: A Guide for Primary Care.” Mayo Clinic Proceedings. July 29, 2000.doi:10.1016/j.mayocp.2020.02.007

(©AdobeStock_280903167)

Related Videos
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
© 2024 MJH Life Sciences

All rights reserved.